CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of <i>RB1</i> Status - Concepedia

Concepedia

Publication | Closed Access

CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of <i>RB1</i> Status

57

Citations

45

References

2018

Year

Carolina Rubio, Mónica Martínez‐Fernández, Cristina Segovia, Iris Lodewijk, Cristian Suárez-Cabrera, Carmen Segrelles, Fernando López-Calderón, Ester Munera-Maravilla, Mirentxu Santos, Alejandra Bernardini,

Clinical Cancer Research

Abstract

CDK4/6 inhibitors, alone or in combination, are a novel therapeutic strategy for patients with advanced bladder cancer previously classified as unfit for current treatment options.

References

	Year	Citations

Page 1